Individual-level response adaptive crossover trial design for epilepsy: structure and simulation
View ORCID ProfileWesley T. Kerr, Xingruo Zhang, View ORCID ProfileJohn M. Stern
doi: https://doi.org/10.1101/2020.10.09.20210286
Wesley T. Kerr
aDepartment of Neurology, David Geffen School of Medicine at the University of California, Los Angeles, Los Angeles, California, USA
bDepartment of Internal Medicine, Eisenhower Health, Rancho Mirage, California, USA
Xingruo Zhang
aDepartment of Neurology, David Geffen School of Medicine at the University of California, Los Angeles, Los Angeles, California, USA
John M. Stern
aDepartment of Neurology, David Geffen School of Medicine at the University of California, Los Angeles, Los Angeles, California, USA
Data Availability
There are no primary data associated with this work.
Posted October 13, 2020.
Individual-level response adaptive crossover trial design for epilepsy: structure and simulation
Wesley T. Kerr, Xingruo Zhang, John M. Stern
medRxiv 2020.10.09.20210286; doi: https://doi.org/10.1101/2020.10.09.20210286
Subject Area
Subject Areas
- Addiction Medicine (382)
- Allergy and Immunology (699)
- Anesthesia (190)
- Cardiovascular Medicine (2838)
- Dermatology (243)
- Emergency Medicine (427)
- Epidemiology (12545)
- Forensic Medicine (10)
- Gastroenterology (801)
- Genetic and Genomic Medicine (4419)
- Geriatric Medicine (401)
- Health Economics (713)
- Health Informatics (2845)
- Health Policy (1046)
- Hematology (373)
- HIV/AIDS (893)
- Medical Education (413)
- Medical Ethics (114)
- Nephrology (461)
- Neurology (4173)
- Nursing (221)
- Nutrition (615)
- Oncology (2199)
- Ophthalmology (623)
- Orthopedics (254)
- Otolaryngology (317)
- Pain Medicine (266)
- Palliative Medicine (81)
- Pathology (485)
- Pediatrics (1171)
- Primary Care Research (482)
- Public and Global Health (6768)
- Radiology and Imaging (1487)
- Respiratory Medicine (898)
- Rheumatology (430)
- Sports Medicine (368)
- Surgery (473)
- Toxicology (57)
- Transplantation (200)
- Urology (173)